Saini, Aman;
Begum, Nazifa;
Matti, James;
Ghanem, Dory Anthony;
Fripp, Laurie;
Pollak, Thomas A;
Zandi, Michael S;
... Rogers, Jonathan; + view all
(2022)
Clozapine as a treatment for catatonia: A systematic review.
Schizophrenia Research
10.1016/j.schres.2022.09.021.
(In press).
Preview |
Text
Lewi_Clozapine as a treatment for catatonia_AOP.pdf - Published Version Download (655kB) | Preview |
Abstract
Catatonia is a neuropsychiatric disorder characterised by altered movement, speech, and behaviour. Clozapine is an established therapy for treatment-resistant schizophrenia, but its role in catatonia has not been systematically examined. In this systematic review, we aimed to assess the evidence for clozapine as a treatment for catatonia. Full text original research articles in English where at least one patient with catatonia was treated with clozapine were included, provided catatonia did not occur solely in the context of neuroleptic malignant syndrome. Results were tabulated with calculations of summary statistics presented. Risk of bias was assessed with the Tool for Evaluating the Methodological Quality of Case Reports and Case Series. 182 patients were included, 81 from cohort studies and 101 from case reports or case series. 119/182 patients (65 %) had a specified underlying diagnosis of schizophrenia. Over 80 % of reported patients with catatonia had at least partial remission following treatment with clozapine across both cohort studies and case reports and case series. Among the case reports and series, 24/101 patients (23.8 %) followed clozapine withdrawal. Overall, 25 studies were of low quality, 60 of moderate quality and 8 of high quality. Our findings should be interpreted with caution, as the reliance on case reports, case series and small cohort studies is susceptible to reporting biases, regression to the mean and confounding by other treatments. Future research could use large healthcare databases to ascertain outcomes in those on clozapine with a history of catatonia given the difficulty and expense of conducting randomised controlled trials.
| Type: | Article |
|---|---|
| Title: | Clozapine as a treatment for catatonia: A systematic review |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.schres.2022.09.021 |
| Publisher version: | https://doi.org/10.1016/j.schres.2022.09.021 |
| Language: | English |
| Additional information: | © 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) |
| Keywords: | Catatonia, Catatonic schizophrenia, Clozapine, Systematic review, Treatment |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry > Institute of Mental Health |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10156362 |
Archive Staff Only
 |
View Item |
